Norvasc Articles
US physicians do not back pharma discount cards or warnings over imports, says study
10 January 2005
Norvasc combi therapy for hypertension
20 December 2004
Dr Reddy's 2nd-qtr profit plummets
8 November 2004
Business update by Bentley Pharma
1 November 2004
US uninsured "pay 78% more than best Rx prices"
1 November 2004
World drug sales up 8% in year to August 2004
25 October 2004
Statins to open door for more US OTC switches?
20 September 2004
KrKa sees net profit rocket 65% for 1st half
20 September 2004
Global Rx drug prices up 8% in year to June 2004
23 August 2004
Combination drugs the new fight against generics?
19 July 2004
Stock Commentary - Europe
16 February 2004
US FDA to re-evaluate Dr Reddy's amlodipine NDA
16 February 2004
Stock Commentary - New York
9 February 2004
Pfizer's Caduet gets OK from FDA
9 February 2004
World retail drug sales grew 8% in year to November 2003, says IMS
30 November 2003
Canadian Rx prices "33%-80% less than in USA"
17 November 2003
Dr Reddy's AmVaz cleared by FDA
10 November 2003
Pfizer reins in 2003 forecast, raises 2004
23 June 2003
Stock Commentary - New York
31 March 2003
Analysts see threat to Novartis' Lotrel
6 January 2003
Pfizer sues Dr Reddy's over Norvasc variant
1 July 2002
Projections confirmed by Pfizer; Niblack retires
10 June 2002
Pfizer 1st-qtr EPS increases 18%
22 April 2002
World drug sales up 12% in year to Feb
22 April 2002
Dr Reddy's files ANDA for generic Norvasc
4 March 2002
World drug sales up 11% in year to Sept
3 December 2001
World retail drug sales grew 11% in 12 months to July 2001, reports IMS
28 September 2001
Viagra, a best-seller for Pfizer Malaysia
28 September 2001
Update - Pfizer second-quarter net income leaps 31%
18 July 2001
Pfizer's UK cardiovascular patient initiative
12 July 2001
Richter hit by move to withdraw drug
22 May 2001
Pfizer 1st-qtr 2001 net income rises 34%
23 April 2001
VALUE study tops enrollment target
2 March 2000
Pfizer EPS in 4th qtr rises 56%
18 January 2000
First approval for B-MS' Tequin heats up antibiotic sector - update
30 December 1999
Dr Reddy's may appeal against lawsuit decision
24 November 1999
B-MS to file for Vanlev approval by year-end
11 November 1999
World's top-selling drugs; 2002 forecasts
13 August 1999
Generic nifedipine gets tentative FDA approval
29 March 1999
Amlodipine Cuts Cardiac Events In CAD Patients
18 November 1998
Pfizer Aims For Top Slot After Millenium
10 November 1998
US Majors Post Strong Earnings For 3rd Quarter
15 October 1998
W-L's Lipitor "Will Be World Top-Seller In 2005"
3 August 1998
"Extraordinary"Viagra Sales Lift Pfizer Earnings
10 July 1998
USA's Most-Dispensed Rx Drugs In April 1998
20 May 1998
Pfizer Posts Double-Digit Sales & Earnings Growth
15 April 1998
Australia Excludes SSRIs From Final TGP Scheme
17 December 1997
Pfizer Invests $179.6 Million In UK Facility
11 December 1997
3rd-Qtr Rx Drug Prices Up 2.9%, Generics Fall 6.4%
25 November 1997
Disappointing 1st Half For Kyowa Hakko
3 November 1997
Pfizer's Healthy Growth Lifted By Alliance Products
16 October 1997
Diovan Versus Norvasc Trial
9 October 1997
Greek Govt Adjusts Prices Of 6,009 Drugs
3 October 1997
GW's Zantac Knocked Off Top US Rx Drug Spot
4 September 1997
Pfizer Enters New Product Cycle With Strong Potential
7 August 1997
Antihypertensive Sales "Set To Decline"
1 August 1997
First Launches For Roche's Posicor
24 July 1997
Pfizer's Good Volume Growth Marred By Strong $
17 July 1997
Pfizer Gets AAA Ranking From S&P
12 June 1997
Forex Impacts Sales At Pfizer, Merck And S-P
22 April 1997
Zocor "Will Be World's Top-Selling Drug In 2005"
13 January 1997
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- US Supreme Court says patent settlement can "sometimes" be illegal
